Fig. 8From: Patient stratification based on urea cycle metabolism for exploration of combination immunotherapy in colon cancerSubdividing colon cancer cases for combination immunotherapy. A The percentage weight of clusters between low- and high-risk groups in the TCGA cohort. B The levels of risk score in two clusters of colon cancer. C The percentage weight of MSI status between low- and high-risk groups in the TCGA cohort. D The levels of risk score in different MSI status. E The Sankey diagram of clusters, risk groups and MSI status of colon cancer cases. F The Sankey diagram of clusters, risk groups and tags of colon cancer cases. G The prediction of potential combination immunotherapeutic agentsBack to article page